cnbc.com / .cnbc-com-europe / Page 4

U.S. private markets firms fell in premarket trading, as concerns over redemption pressure returned to the spotlight.

One analyst said markets would reprice U.K. fiscal risk "accordingly and quickly" if Burnham's political ambitions come to light.

Novo's approach to global launches will be guided by patient demand and the strength of healthcare and telehealth infrastructure, the drugmaker said.

The OECD has cut its global growth outlook, warning of lasting damage caused by the Middle East conflict.

English football appears to be riding high following Arsenal's Premier League win. But scratch beneath the surface and all is not as good as it looks.

The U.S. is reportedly exploring plans to expand its nuclear weapons-hosting arrangements to include more NATO countries in Europe.

Shares of French biotech Abivax tumbled 32% after it reported fresh data on its lead asset.

Anthropic is sharing access to its most advanced AI model, Mythos, with the EU after the region sought permission over cybersecurity concerns.

The AI revolution will be 50 times bigger than the Dotcom revolution in the 2000s, SoftBank CEO Masayoshi Son told CNBC Monday.

Shares in software compares surged ahead of Monday's opening bell.